United States Biopharmaceuticals Market Report & Forecast 2021-2027

Publisher Name :
Date: 09-Sep-2021
No. of pages: 110
Inquire Before Buying

United States Biopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Biopharmaceuticals Market Segment Percentages, By Type, 2020 (%)

- Monoclonal Antibodies

- Interferon

- Colony-Stimulating Factor

- Erythropoietin

- Insulin

- Vaccines

- Growth Hormones

- Others

United States Biopharmaceuticals Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Biopharmaceuticals Market Segment Percentages, By Application, 2020 (%)

- Tumor

- Diabetes

- Cardiovascular

- Hemophilia

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biopharmaceuticals revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Biopharmaceuticals revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Roche

- Amgen

- AbbVie

- Sanofi-Aventis

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Eli Lilly

- Novartis

- Merck

- Sun

- 3sbio

- Changchun High Tech

- CP Guojian

- Biotech

- Gelgen

- Innovent

- Dong Bao

- Ganlee

- United Laboratories

- SANDOZ (NOVARTIS)

- Teva Pharmaceutical

- Hospira ?Pfizer?

- MYLAN

- Sun pharma

United States Biopharmaceuticals Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Biopharmaceuticals Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Biopharmaceuticals Overall Market Size
2.1 United States Biopharmaceuticals Market Size: 2021 VS 2027
2.2 United States Biopharmaceuticals Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceuticals Players in United States Market
3.2 Top United States Biopharmaceuticals Companies Ranked by Revenue
3.3 United States Biopharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceuticals Companies in United States Market, by Revenue in 2020
3.5 Companies Biopharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceuticals Players in United States Market
3.6.1 List of Tier 1 Biopharmaceuticals Companies in United States
3.6.2 List of Tier 2 and Tier 3 Biopharmaceuticals Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Biopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Colony-Stimulating Factor
4.1.5 Erythropoietin
4.1.6 Insulin
4.1.7 Vaccines
4.1.8 Growth Hormones
4.1.9 Others
4.2 By Type - United States Biopharmaceuticals Revenue & Forecasts
4.2.1 By Type - United States Biopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - United States Biopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - United States Biopharmaceuticals Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Biopharmaceuticals Market Size, 2021 & 2027
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - United States Biopharmaceuticals Revenue & Forecasts
5.2.1 By Application - United States Biopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - United States Biopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - United States Biopharmaceuticals Revenue Market Share, 2016-2027
6 Biopharmaceuticals Companies Profiles
6.1 Roche
6.1.1 Roche Company Details
6.1.2 Roche Business Overview
6.1.3 Roche Biopharmaceuticals Introduction
6.1.4 Roche Biopharmaceuticals Revenue in United States Market (2016-2021)
6.1.5 Roche Recent Developments
6.2 Amgen
6.2.1 Amgen Company Details
6.2.2 Amgen Business Overview
6.2.3 Amgen Biopharmaceuticals Introduction
6.2.4 Amgen Biopharmaceuticals Revenue in United States Market (2016-2021)
6.2.5 Amgen Recent Developments
6.3 AbbVie
6.3.1 AbbVie Company Details
6.3.2 AbbVie Business Overview
6.3.3 AbbVie Biopharmaceuticals Introduction
6.3.4 AbbVie Biopharmaceuticals Revenue in United States Market (2016-2021)
6.3.5 AbbVie Recent Developments
6.4 Sanofi-Aventis
6.4.1 Sanofi-Aventis Company Details
6.4.2 Sanofi-Aventis Business Overview
6.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
6.4.4 Sanofi-Aventis Biopharmaceuticals Revenue in United States Market (2016-2021)
6.4.5 Sanofi-Aventis Recent Developments
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Details
6.5.2 Johnson & Johnson Business Overview
6.5.3 Johnson & Johnson Biopharmaceuticals Introduction
6.5.4 Johnson & Johnson Biopharmaceuticals Revenue in United States Market (2016-2021)
6.5.5 Johnson & Johnson Recent Developments
6.6 Pfizer
6.6.1 Pfizer Company Details
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Biopharmaceuticals Introduction
6.6.4 Pfizer Biopharmaceuticals Revenue in United States Market (2016-2021)
6.6.5 Pfizer Recent Developments
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Details
6.7.2 Novo Nordisk Business Overview
6.7.3 Novo Nordisk Biopharmaceuticals Introduction
6.7.4 Novo Nordisk Biopharmaceuticals Revenue in United States Market (2016-2021)
6.7.5 Novo Nordisk Recent Developments
6.8 Eli Lilly
6.8.1 Eli Lilly Company Details
6.8.2 Eli Lilly Business Overview
6.8.3 Eli Lilly Biopharmaceuticals Introduction
6.8.4 Eli Lilly Biopharmaceuticals Revenue in United States Market (2016-2021)
6.8.5 Eli Lilly Recent Developments
6.9 Novartis
6.9.1 Novartis Company Details
6.9.2 Novartis Business Overview
6.9.3 Novartis Biopharmaceuticals Introduction
6.9.4 Novartis Biopharmaceuticals Revenue in United States Market (2016-2021)
6.9.5 Novartis Recent Developments
6.10 Merck
6.10.1 Merck Company Details
6.10.2 Merck Business Overview
6.10.3 Merck Biopharmaceuticals Introduction
6.10.4 Merck Biopharmaceuticals Revenue in United States Market (2016-2021)
6.10.5 Merck Recent Developments
6.11 Sun
6.11.1 Sun Company Details
6.11.2 Sun Business Overview
6.11.3 Sun Biopharmaceuticals Introduction
6.11.4 Sun Biopharmaceuticals Revenue in United States Market (2016-2021)
6.11.5 Sun Recent Developments
6.12 3sbio
6.12.1 3sbio Company Details
6.12.2 3sbio Business Overview
6.12.3 3sbio Biopharmaceuticals Introduction
6.12.4 3sbio Biopharmaceuticals Revenue in United States Market (2016-2021)
6.12.5 3sbio Recent Developments
6.13 Changchun High Tech
6.13.1 Changchun High Tech Company Details
6.13.2 Changchun High Tech Business Overview
6.13.3 Changchun High Tech Biopharmaceuticals Introduction
6.13.4 Changchun High Tech Biopharmaceuticals Revenue in United States Market (2016-2021)
6.13.5 Changchun High Tech Recent Developments
6.14 CP Guojian
6.14.1 CP Guojian Company Details
6.14.2 CP Guojian Business Overview
6.14.3 CP Guojian Biopharmaceuticals Introduction
6.14.4 CP Guojian Biopharmaceuticals Revenue in United States Market (2016-2021)
6.14.5 CP Guojian Recent Developments
6.15 Biotech
6.15.1 Biotech Company Details
6.15.2 Biotech Business Overview
6.15.3 Biotech Biopharmaceuticals Introduction
6.15.4 Biotech Biopharmaceuticals Revenue in United States Market (2016-2021)
6.15.5 Biotech Recent Developments
6.16 Gelgen
6.16.1 Gelgen Company Details
6.16.2 Gelgen Business Overview
6.16.3 Gelgen Biopharmaceuticals Introduction
6.16.4 Gelgen Biopharmaceuticals Revenue in United States Market (2016-2021)
6.16.5 Gelgen Recent Developments
6.17 Innovent
6.17.1 Innovent Company Details
6.17.2 Innovent Business Overview
6.17.3 Innovent Biopharmaceuticals Introduction
6.17.4 Innovent Biopharmaceuticals Revenue in United States Market (2016-2021)
6.17.5 Innovent Recent Developments
6.18 Dong Bao
6.18.1 Dong Bao Company Details
6.18.2 Dong Bao Business Overview
6.18.3 Dong Bao Biopharmaceuticals Introduction
6.18.4 Dong Bao Biopharmaceuticals Revenue in United States Market (2016-2021)
6.18.5 Dong Bao Recent Developments
6.19 Ganlee
6.19.1 Ganlee Company Details
6.19.2 Ganlee Business Overview
6.19.3 Ganlee Biopharmaceuticals Introduction
6.19.4 Ganlee Biopharmaceuticals Revenue in United States Market (2016-2021)
6.19.5 Ganlee Recent Developments
6.20 United Laboratories
6.20.1 United Laboratories Company Details
6.20.2 United Laboratories Business Overview
6.20.3 United Laboratories Biopharmaceuticals Introduction
6.20.4 United Laboratories Biopharmaceuticals Revenue in United States Market (2016-2021)
6.20.5 United Laboratories Recent Developments
6.21 SANDOZ (NOVARTIS)
6.21.1 SANDOZ (NOVARTIS) Company Details
6.21.2 SANDOZ (NOVARTIS) Business Overview
6.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction
6.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue in United States Market (2016-2021)
6.21.5 SANDOZ (NOVARTIS) Recent Developments
6.22 Teva Pharmaceutical
6.22.1 Teva Pharmaceutical Company Details
6.22.2 Teva Pharmaceutical Business Overview
6.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction
6.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue in United States Market (2016-2021)
6.22.5 Teva Pharmaceutical Recent Developments
6.23 Hospira ?Pfizer?
6.23.1 Hospira ?Pfizer? Company Details
6.23.2 Hospira ?Pfizer? Business Overview
6.23.3 Hospira ?Pfizer? Biopharmaceuticals Introduction
6.23.4 Hospira ?Pfizer? Biopharmaceuticals Revenue in United States Market (2016-2021)
6.23.5 Hospira ?Pfizer? Recent Developments
6.24 MYLAN
6.24.1 MYLAN Company Details
6.24.2 MYLAN Business Overview
6.24.3 MYLAN Biopharmaceuticals Introduction
6.24.4 MYLAN Biopharmaceuticals Revenue in United States Market (2016-2021)
6.24.5 MYLAN Recent Developments
6.25 Sun pharma
6.25.1 Sun pharma Company Details
6.25.2 Sun pharma Business Overview
6.25.3 Sun pharma Biopharmaceuticals Introduction
6.25.4 Sun pharma Biopharmaceuticals Revenue in United States Market (2016-2021)
6.25.5 Sun pharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Biopharmaceuticals Market Opportunities & Trends in United States Market
Table 2. Biopharmaceuticals Market Drivers in United States Market
Table 3. Biopharmaceuticals Market Restraints in United States Market
Table 4. Key Players of Biopharmaceuticals in United States Market
Table 5. Top Biopharmaceuticals Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Biopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Biopharmaceuticals Revenue Share by Companies, 2016-2021
Table 8. Companies Biopharmaceuticals Product Type
Table 9. List of Tier 1 Biopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Biopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Biopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Biopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Biopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Biopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 17. Roche Company Details
Table 18. Roche Business Overview
Table 19. Roche Biopharmaceuticals Product
Table 20. Roche Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Roche Recent Developments
Table 22. Amgen Company Details
Table 23. Amgen Business Overview
Table 24. Amgen Biopharmaceuticals Product
Table 25. Amgen Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Amgen Recent Developments
Table 27. AbbVie Company Details
Table 28. AbbVie Business Overview
Table 29. AbbVie Biopharmaceuticals Product
Table 30. AbbVie Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. AbbVie Recent Developments
Table 32. Sanofi-Aventis Company Details
Table 33. Sanofi-Aventis Business Overview
Table 34. Sanofi-Aventis Biopharmaceuticals Product
Table 35. Sanofi-Aventis Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Sanofi-Aventis Recent Developments
Table 37. Johnson & Johnson Company Details
Table 38. Johnson & Johnson Business Overview
Table 39. Johnson & Johnson Biopharmaceuticals Product
Table 40. Johnson & Johnson Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Johnson & Johnson Recent Developments
Table 42. Pfizer Company Details
Table 43. Pfizer Business Overview
Table 44. Pfizer Biopharmaceuticals Product
Table 45. Pfizer Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Pfizer Recent Developments
Table 47. Novo Nordisk Company Details
Table 48. Novo Nordisk Business Overview
Table 49. Novo Nordisk Biopharmaceuticals Product
Table 50. Novo Nordisk Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Novo Nordisk Recent Developments
Table 52. Eli Lilly Company Details
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Biopharmaceuticals Product
Table 55. Eli Lilly Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Eli Lilly Recent Developments
Table 57. Novartis Company Details
Table 58. Novartis Business Overview
Table 59. Novartis Biopharmaceuticals Product
Table 60. Novartis Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Novartis Recent Developments
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Biopharmaceuticals Product
Table 65. Merck Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Merck Recent Developments
Table 67. Sun Company Details
Table 68. Sun Business Overview
Table 69. Sun Biopharmaceuticals Product
Table 70. Sun Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Sun Recent Developments
Table 72. 3sbio Company Details
Table 73. 3sbio Business Overview
Table 74. 3sbio Biopharmaceuticals Product
Table 75. 3sbio Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. 3sbio Recent Developments
Table 77. Changchun High Tech Company Details
Table 78. Changchun High Tech Business Overview
Table 79. Changchun High Tech Biopharmaceuticals Product
Table 80. Changchun High Tech Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Changchun High Tech Recent Developments
Table 82. CP Guojian Company Details
Table 83. CP Guojian Business Overview
Table 84. CP Guojian Biopharmaceuticals Product
Table 85. CP Guojian Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. CP Guojian Recent Developments
Table 87. Biotech Business Overview
Table 88. Biotech Company Details
Table 89. Biotech Biopharmaceuticals Product
Table 90. Biotech Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. Biotech Recent Developments
Table 92. Gelgen Company Details
Table 93. Gelgen Business Overview
Table 94. Gelgen Biopharmaceuticals Product
Table 95. Gelgen Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 96. Gelgen Recent Developments
Table 97. Innovent Company Details
Table 98. Innovent Business Overview
Table 99. Innovent Biopharmaceuticals Product
Table 100. Innovent Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 101. Innovent Recent Developments
Table 102. Dong Bao Company Details
Table 103. Dong Bao Business Overview
Table 104. Dong Bao Biopharmaceuticals Product
Table 105. Dong Bao Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 106. Dong Bao Recent Developments
Table 107. Ganlee Company Details
Table 108. Ganlee Business Overview
Table 109. Ganlee Biopharmaceuticals Product
Table 110. Ganlee Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 111. Ganlee Recent Developments
Table 112. United Laboratories Company Details
Table 113. United Laboratories Business Overview
Table 114. United Laboratories Biopharmaceuticals Product
Table 115. United Laboratories Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 116. United Laboratories Recent Developments
Table 117. SANDOZ (NOVARTIS) Company Details
Table 118. SANDOZ (NOVARTIS) Business Overview
Table 119. SANDOZ (NOVARTIS) Biopharmaceuticals Product
Table 120. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 121. SANDOZ (NOVARTIS) Recent Developments
Table 122. Teva Pharmaceutical Company Details
Table 123. Teva Pharmaceutical Business Overview
Table 124. Teva Pharmaceutical Biopharmaceuticals Product
Table 125. Teva Pharmaceutical Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 126. Teva Pharmaceutical Recent Developments
Table 127. Hospira ?Pfizer? Company Details
Table 128. Hospira ?Pfizer? Business Overview
Table 129. Hospira ?Pfizer? Biopharmaceuticals Product
Table 130. Hospira ?Pfizer? Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 131. Hospira ?Pfizer? Recent Developments
Table 132. MYLAN Company Details
Table 133. MYLAN Business Overview
Table 134. MYLAN Biopharmaceuticals Product
Table 135. MYLAN Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 136. MYLAN Recent Developments
Table 137. Sun pharma Company Details
Table 138. Sun pharma Business Overview
Table 139. Sun pharma Biopharmaceuticals Product
Table 140. Sun pharma Biopharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million)
Table 141. Sun pharma Recent Developments
List of Figures
Figure 1. Biopharmaceuticals Segment by Type
Figure 2. Biopharmaceuticals Segment by Application
Figure 3. United States Biopharmaceuticals Market Overview: 2020
Figure 4. United States Biopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Biopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Biopharmaceuticals Revenue in 2020
Figure 7. By Type - United States Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 8. By Application - United States Biopharmaceuticals Revenue Market Share, 2016-2027
Figure 9. Roche Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Amgen Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. AbbVie Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sanofi-Aventis Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Johnson & Johnson Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Pfizer Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Novo Nordisk Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Eli Lilly Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Novartis Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Merck Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Sun Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. 3sbio Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Changchun High Tech Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. CP Guojian Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Biotech Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Gelgen Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Innovent Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Dong Bao Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Ganlee Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. United Laboratories Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Teva Pharmaceutical Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Hospira ?Pfizer? Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. MYLAN Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Sun pharma Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Biopharmaceuticals Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 08-Oct-2021        Price: US 3480 Onwards        Pages: 110
    The Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest rese......
  • Global and China Bio-pharma Market Insights, Forecast to 2027
    Published: 20-Sep-2021        Price: US 3900 Onwards        Pages: 143
    Bio-pharma market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bio-pharma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Bio-pharma market size by players, ......
  • United States Biopharmaceuticals Market Report & Forecast 2021-2027
    Published: 09-Sep-2021        Price: US 3400 Onwards        Pages: 110
    United States Biopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Biopharmaceuticals Market Segment Percentages, By Type, 2020 (%) - Monoclonal Antibodies - Interferon - Colony-Stimulating Factor - Erythropoietin - Insulin - Vaccines - Growth Hormones - Others United States Biopharmaceuticals Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Biopharmaceutical......
  • Global Calcium Suppliment Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 99
    The Calcium Suppliment market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Calcium Suppliment Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Calcium Suppliment industry, providing statistical information about market dynamics, growth factors......
  • Global Advanced Wound Dressing Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 99
    The Advanced Wound Dressing market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Advanced Wound Dressing Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Advanced Wound Dressing industry, providing statistical information about market dynamics,......
  • Global Cefotaxime Sodium API Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 107
    The Cefotaxime Sodium API market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Cefotaxime Sodium API Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Cefotaxime Sodium API industry, providing statistical information about market dynamics, growt......
  • Global Empty Hard Gelatin Capsules Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 98
    Gelatin is considered to be animal proteins that are utilized to prepare capsules, which gives calculated quantities of products. Empty hard gelatin capsules are made from gelatin (Gelatin is a translucent, colorless, brittle (when dry), flavorless solid substance, derived from the collagen- an animal protein). Empty Hard Gelatin Capsules contain 12 - 16% moisture. But the moisture content can vary up on the storage conditions. The Empty Hard Gelatin Capsules market revenue was xx Million......
  • Global Phytotherapics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 117
    The Phytotherapics market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Phytotherapics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Phytotherapics industry, providing statistical information about market dynamics, growth factors, major chal......
  • Global P2X7 Receptor Antagonists Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 122
    The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not exclusively, on immune cells. P2X7 activation results in a number of downstream events, including the release of proinflammatory mediators and cell death and proliferation. The P2X7 Receptor Antagonists market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global P2X7 Receptor Antagonists Market Develop......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs